Alcon (NYSE:ALC) (NYSE: ALC) is a global eye care company focused on the development, manufacture and commercialization of surgical equipment and vision care products. Founded in 1945, Alcon has built a portfolio that supports ophthalmic surgeons, optometrists and consumers with technologies and consumables used in cataract and retinal surgery as well as daily vision care needs. The company returned to independent public-company status through a corporate separation completed in 2019.
In its surgical business, Alcon provides a range of products and systems for cataract removal, intraocular lens implantation and vitreoretinal procedures, alongside related consumables and instrumentation. The company’s offerings are used in hospital and ambulatory surgical settings and are supported by clinical training, surgical support services and product-related research aimed at improving procedural outcomes and surgical efficiency.
Alcon’s vision care segment supplies contact lenses, lens care solutions and a variety of consumer eye-care products designed for daily wearers and eye-care professionals. These products are distributed through eye-care practices, retail channels and direct partnerships with healthcare providers. The company emphasizes product innovation, quality manufacturing and regulatory compliance to meet the needs of patients and practitioners in diverse clinical and consumer settings.
Operating on a global scale, Alcon markets and sells its products across the Americas, Europe, Asia-Pacific and other regions, collaborating with surgeons, optometrists and distributors worldwide. The company maintains research and development and manufacturing activities to support new product introductions and to respond to evolving standards in ophthalmic care and vision health.
